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Toll-like receptorseptors (TLR) are known to mediate the metabolic complications of obesity, the
mechanisms underlying its activation remain largely unknown. The present study analyzed a model of diet-
induced obesity in mice lacking the TLR4/TLR2 co-receptor CD14.
Main methods: Six-week-old male mice lacking CD14 (n=16) were allocated to either a control diet or a high-
fat high-simple carbohydrate diet (5.4 kcal/g; 35% fat; 35% sucrose), and compared with C57BL/6 (WT; n=15)
controls. After 12 weeks, body composition, basal sympathetic activity, non-invasive blood pressure and
glucose tolerance were evaluated. Hepatic and adipose tissues were collected for mRNA quantiﬁcation,
histology and LPS incubation.
Key ﬁndings: In both WT and CD14 knockout mice, obesity was accompanied by TLR2 and TLR4 upregulation.
However, obese mice lacking CD14 presented decreased lipid and macrophage content in hepatic and adipose
tissues, lower urinary levels of noradrenaline, decreased systolic blood pressure, reduced fasting plasma
glucose and blunted glucose intolerance, comparedwith obeseWTgroup. In the presence of exogenous sCD14,
adipose tissue incubation with LPS-induced TLR2 and TNF-α upregulation in both WT and CD14 knockout
obese mice.
Signiﬁcance: In our model of diet-induced obesity, mice lacking CD14 showed lower adiposity and hepatic
steatosis, improved glucose homeostasis, blunted sympathetic overactivity and reduced blood pressure
elevation. This was observed in the presence of preserved TLR4 and TLR2 gene expression, and intact TLR4
signaling pathways. These results suggest that CD14-mediated TLR activation might contribute to the
cardiovascular and metabolic complications of obesity.
© 2008 Elsevier Inc. All rights reserved.Introduction
Toll-like receptors (TLRs) recognize conserved pathogen-asso-
ciated molecular patterns (PAMPs) and play a critical role in innate
immune system activation in response to invading microorganisms
(Akira, 2003). Signaling through TLR2 and TLR4 is mediated by CD14, a
co-receptor found in two forms: a 50 to 55 kD glycosylphosphatidy-
linositol-anchored membrane protein (mCD14), expressed only in
myeloid cells, and a monocyte- or liver-derived soluble serum protein
that lacks the anchor (sCD14) (Kirschning et al., 1998; Pugin et al.,
1994; Wright et al., 1990; Yang et al., 1998). Both protein forms are
critical for signal transduction, with sCD14 conferring sensitivity to
cells lacking mCD14. Although a variety of ligands can be recognized0-319, Porto-Portugal. Tel.: +351
eira).
l rights reserved.by CD14 (e.g. bacterial lipopolysaccharide (LPS), mycobacterial
lipoarabinomannan (LAM)), subsequent TLR-mediated cell activation
occurs in a ligand speciﬁc manner (Means et al., 1999).
Obesity is a state of chronic low-grade inﬂammation associated
with an array of cardiovascular and metabolic complications (Semen-
kovich, 2006). Recent studies have proposed several causal links
between TLR signaling and the metabolic complications of obesity.
Firstly, TLR4 expression has been consistently demonstrated in
adipocytes being upregulated in fat tissues of db/db mice (Lin et al.,
2000), and TLR4 activation has been shown to induce insulin
resistance, both in vitro and in vivo (Song et al., 2006). Secondly, in
a mouse model of obesity, exposure to a high-fat diet during 4 weeks
induced an increase of plasma LPS concentration by 2–3 times, a
threshold deﬁned as ‘metabolic endotoxemia’ (Cani et al., 2007).
Finally, nutritional fatty acids, whose circulating levels are often
increased in obesity, have also been shown to activate TLR signaling in
adipocytes and macrophages (Lee and Hwang, 2006). The expression
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fatty acid was blocked by a dominant-negative mutant of TLR4 or
TLR2, while various unsaturated fatty acids suppressed NFκB activa-
tion induced by the TLR4 agonist LPS (Lee et al., 2003). It remains,
however, to be established, the relative contribution of ‘metabolic
endotoxemia’ and nutritional fatty acids in the TLR-mediated meta-
bolic complications of obesity. Furthermore, data is lacking regarding
the impact of TLR activation on the cardiovascular complications of
obesity such as hypertension.
To further clarify the mechanisms underlying TLR activation in
obesity, we studied the effect of a high-fat high-simple carbohydrate
(HFHSC) diet on CD14, TLR2 and TLR4 gene expression proﬁle, as well
as on LPS-induced TLR4 activation. Furthermore, the effects of the
HFHSC diet on body composition, basal sympathetic activity and
systolic blood pressure, glucose homeostasis and hepatic steatosis
were compared in C57BL/6 control and CD14 homozygous null mice.
Materials and methods
Animal experiments were performed according to the Portuguese
law on animal welfare and conform to the National Institutes of Health
Guide for the Care and Use of Laboratory Animals (NIH. Pub. No. 85-23,
Revised 1996). Five-week-old male C57BL/6 mice (WT; n=15) and
CD14 mutant bred in a C57BL/6 background (CD14−/−, n=16) male
micewere purchased from The Jackson Laboratory (Bar Harbor, Maine,
USA). Animals were housed in groups of 5 per cage in a controlled
environment under 12:12 h light-dark cycle, at a room temperature of
21 °C, with a free supply of water. Mice were allowed 1 week of
adaptation to laboratory conditions before entering the experiments.
At six weeks of age animals were allocated to either a control diet
(Teklad LM-485Mouse/Rat Sterilizable Diet) with 4.1 kcal/g composed
of 5% fat, 54% carbohydrate (ground corn), 19% protein, 5% ﬁber, 0.31%
sodium and 0.85% potassium (WT, n=7; CD14−/−, n=8), or a high-fat
high-simple carbohydrate diet (HFHSC; Diet F2685; BioServe) with
5.4 kcal/g composed of 35% fat (lard), 35% simple carbohydrate
(sucrose), 20% protein, 0.1% ﬁber, 0.39% sodium and 0.56% potassium
(WT, n=8; CD14−/−, n=9). Body weight, food and water ingestionwere
measured weekly throughout the study. This experimental model has
been previously shown to induce obesity, type 2 diabetes mellitus and
hypertension in C57BL/6 mice (Mills et al., 1993).
After 12 weeks, non-invasive blood pressure was recorded and
glucose tolerance and insulin resistance tests were performed (see
below). Mice were then placed in metabolic cages (Tecniplast,
Buguggiate-VA, Italy) and 24 h urine was collected for noradrenaline
quantiﬁcation (see below). Finally, animals were sacriﬁced by sodium
pentobarbital overdose, the right tibial length was measured, liver,
right gastrocnemius and right gonadal fat pad were weighed, and
tissue samples were extracted for incubation tests, mRNA and
triglyceride quantiﬁcation and histology. Subcutaneous fat samples
were collected from the gonadal fat pad and visceral fat samples were
extracted from mesenteric adipose tissue. The proportional weight of
the gonadal fat pad (PWGFP) was used as an estimate of total body fat.
The PWGFP is deﬁned as the right gonadal fat pad weight in
percentage of total body weight. This has been previously shown to
closely correlate with the direct measurement of body fat in normal
and obese mice (Rogers and Webb, 1980).
Blood pressure measurements in awake mice
Systolic blood pressure was assessed in awake animals using a
photoelectric tail-cuff pulse detector (LE 5000, Letica). From 09h00 to
13h00, mice were sited into a semicylindrical container placed in a
temperature control box at 36–37 °C. Animals were previously
conditioned to the restrainer by repeating inﬂation–deﬂation cycles
for∼30min every 2weeks from the start of the experimental protocol.
Before measurements, animals were conditioned to the restrainer byrepeating inﬂation–deﬂation cycles for 15 min. At 12 weeks, a
minimum of ﬁve reliable systolic blood pressure measurements were
obtained for each animal and averaged.
Glucose tolerance and insulin resistance tests
Glucose tolerance tests were carried out at 22h00 after a 14-h fast
through a single intraperitoneal injection of dextrose inwater (1.0 g/kg).
Blood glucose concentrationwasmeasured before and 15, 30, 45, 60, 90,
120 and 150 min after injection using a blood glucose meter (Freestyle
Mini™ system). Insulin resistance was tested after a 6 h fast through a
single intraperitoneal injection of insulin, 1.5 U/kg (Actrapid® Novo
Nordisk). Measurements were made before and 15, 30, 45, 60 and
90 min after injection.
24-h urine catecholamine determination
Urine concentrations of noradrenaline were quantiﬁed by means
of HPLC with electrochemical detection, as previously described
(Pestana and Soares-da-Silva, 1994). The lower limits of detection of
noradrenaline ranged from 350 to 500 fmol.
Measurement of hepatic triglyceride content
Hepatic triglyceride content was quantiﬁed using a Cobas Mira
Plus analyzer (ABX Diagnostics) after extraction of lipids from 50 mg
of liver tissue with 1 ml 2:1 chloroform–methanol (v/v), according to
the method by Folch et al. (1957), drying for ∼4 h at 60 °C and
dissolution in 600 μl isopropanol.
Histological analysis
Hepatic and subcutaneousadipose tissuewereﬁxed for12–24hwith
10% formalin at room temperature, embedded inparafﬁn, and cut into 4-
μm-thick sections. Sections were stained with hematoxylin–eosin.
Adipose tissue macrophage and TLR4 immunodetection was
performed with an anti-F4/80 monoclonal antibody (CALTAG Labora-
tories), and a rabbit TLR4 antiserum (Abcam), respectively. In all tissue
blocks, 15–20 different ×20 ﬁelds from each of 4 different sections
were analyzed. In each ﬁeld, the number of F4/80-expressing cells was
counted, along with the total number of nuclei. Average adipocyte
diameter was determined measuring all adipocytes in every ﬁeld
analyzed, using image analysis software (Leica Application System).
Adipose tissue incubations
The left gonadal fat pads of WT and CD14−/− mice were dissected
under sterile conditions, minced, and incubated in culture medium
(1.5 ml of media per gram of tissue) containing DMEM and Ham's F-12
in a 1:1 mixture, supplemented with 10% (v/v) newborn calf serum
that supplies sCD14. The incubation solution also contained 1 nM
3,3′,5-triiodo-L-thyronine, 5 mM glutamine, penicillin (6.35 mg/l) and
streptomycin (5 mg/l). The time between excision of adipose tissue
and initiation of incubation was 15 to 30 min. For each animal, two
adipose tissue samples were prepared, with either LPS (5 μg/ml; γ-
irradiated lipopolysaccharides from Escherichia coli 0111:B4; Sigma
L4391) or the vehicle (Control). The samples were incubated at 37 °C
with an atmosphere of 95% O2 and 5% CO2 (vol/vol) in 1.5 ml aliquots,
whichwere gently swirled every 15min for 2 h. The adipose tissue and
the supernatantwere then quickly frozen and stored at −80 °C for later
mRNA and protein quantiﬁcation, respectively.
mRNA quantiﬁcation
After collection, samples were quickly immersed in RNAlater
(Qiagen) and frozen (−80 °C). Total mRNA was extracted through the
Table 1
Body composition and fasting plasma glucose of WT and CD14−/− mice after 12 weeks of diet exposure
Genotype Diet Body weight (g) PWGFP (% g/g) Gastrocn. (g) Liver weight (g) Tibial length (cm) FPG (mg/dl)
WT Control 27.3±0.82 0.65±0.13 0.19±0.064 1.2±0.19 1.7±0.08 124±7.8
CD14−/− Control 27.0±0.99 0.58±0.11 0.14±0.036 0.93±0.059 1.8±0.07 136±6.3
WT HFHSC 41.8±1.64* 2.7±0.41* 0.20±0.013 1.2±0.063 1.8±0.02 245±13.7*
CD14−/− HFHSC 42.4±2.53* 2.0±0.54*† 0.33±0.097*†§ 1.3±0.36* 1.7±0.06 192±6.5*†
Values are expressed asmean±SEM; CD14−/−,CD14 knockoutmice; FPG, fasting plasma glucose; Gastrocn, gastrocnemiusmuscle mass; HFHSC, high-fat high-simple carbohydrate diet;
PWGFP, proportional weight of the right gonadal fat pad; WT, C57BL/6 mice; *Pb0.05 vs. Control diet; †Pb0.05 vs. WT; § signiﬁcant interaction.
Fig. 1. Body weight, food and water ingestion of obeseWTand CD14−/−mice. (A) Obesity
was induced by ad libitum exposure to a high-fat high-simple carbohydrate (HFHSC)
diet for 12 weeks. At the end of the third week, WT and CD14−/− mice exposed to the
HFHSC diet already presented higher body weights than the respective lean controls. No
signiﬁcant differences were detected in weight gain between obese WT and CD14−/−
groups. This was accompanied by similar food (B) and water (C) ingestion in obese WT
and CD14−/− groups. CD14−/−, CD14 knockout mice; WT, C57BL/6 mice; *Pb0.05 vs. Lean.
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method (Qiagen 74124) according to the manufacturer's instructions.
Concentration and purity were assayed by spectrophotometry
(Eppendorf 6131000.012). Two-step real-time RT-PCR was used to
perform relative quantiﬁcation of mRNA. For each studied mRNA
molecule, standard curves were generated from the correlation
between the amount of starting total mRNA and PCR threshold cycle
(second derivative maximum method) of graded dilutions from a
randomly selected tissue sample (rN0.97). For relative quantiﬁcation
of speciﬁc mRNA levels, 50 ng of total mRNA from each sample
underwent two-step real-time RT-PCR. A melt curve analysis of each
real-time PCR and 2% agarose gels (0.5 µg/ml ethidium bromide) were
performed to exclude primer-dimer formation and assess the purity of
the ampliﬁcation product. Glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH) mRNA levels were similar in all experimental groups,
which enabled the use of this gene as internal control. Results of
mRNA quantiﬁcation are expressed in an arbitrary unit (AU) set as the
average value of WT—Lean group (1 AU), after normalization for
GAPDH. RT (20 µl; 10min at 22 °C, 50min at 50 °C and 10min at 95 °C)
was performed in a standard thermocycler (Whatman Biometra 050-
901): 40 U/reaction of reverse transcriptase (Invitrogen 18064-014),
20 U/reaction of RNase inhibitor (Promega N2515), 30 ng/ml random
primers (Invitrogen 48190-011), 0.5 mM nucleotide mix (MBI
Fermentas R0192), 1.9 mM MgCl2 and 10 mM DTT. Ten percent of
the cDNA yield was used as a template for real-time PCR (LightCycler
II, Roche) using SYBR green (Qiagen 204143) according to the
manufacturer's instructions. Speciﬁc PCR primer pairs for the studied
genes were: GAPDH—fw 5′-GAG GCC GGT GCT GAG TAT GTC GTG -3′
and rev 5′-TCGGCAGAAGGGGCGGAGAT-3′;CD14—fw5′-GCCTCTCCC
GCC CCA CCA G -3′ and rev 5′-CCG CCG CCG TAC AAT TCC ACA TC-3′;
TLR2—fw 5′-ACAGGGATCCGGGTGGTAAAAAC-3′ and rev 5′-GCAGCC
GAGGCAAGAACAAAGA-3′;TLR4—fw5′-GATTTATCCAGGTGTGAA-3′
and rev 5′-CCT GGG GAA AAA CTC TGG ATA G-3′; TNF-α—fw 5′-AGG
GGC CAC CAC GCT CTT CTGTC-3′ and rev 5′-GAT GAT CTGAGTGTGAGG
GTC TGG-3′.
TNF-α protein quantiﬁcation
TNF-α quantiﬁcation by ELISA was performed in the supernatants
of the adipose tissue cultures at the end of the 120 min incubations,
according to the manufacturer's instructions (Abcam ab46105).
Statistical analysis
Data are presented as mean±SEM. To assess the effect of genotype
and diet for quantitative phenotypes, two-wayANOVAwas performed.
Statistical signiﬁcance was set at Pb0.05.
Results
Diet-induced obesity in WT and CD14−/− mice
Lean WT and CD14−/− mice presented similar body weights,
PWGFP, adipocyte size, gastrocnemius muscle mass and tibial length
(Table 1). However, a trend towards lower liver weight was observedin lean CD14−/− mice compared with the respective WT group, and
obesity was accompanied by a signiﬁcant increase in liver weight in
the transgenic strain.
Exposure to the HFHSC diet was accompanied by progressive
obesity in WT mice (Fig. 1A). By 2 weeks the weight differences were
already signiﬁcant and at 12 weeks the weight of obese WT mice was
53% higher than that of lean WT mice. This was accompanied by
increased body fat, as assessed by PWGFP (Table 1) and adipocyte size
(Fig. 2A), with no signiﬁcant differences in gastrocnemius muscle
mass, liver weight or tibial length (Table 1).
Obesity was also present in CD14−/− mice fed the HFHSC diet
(Fig. 1A). Despite the similar weight gain observed in obese WT and
CD14−/− mice, the transgenic group presented lower PWGFP (Table 1)
and adipocyte size (Fig. 2A), and higher gastrocnemius muscle mass
(Table 1). This could not be attributed to differences in caloric intake or
water ingestion between obeseWTand CD14−/− groups (Fig. 1B and C).
Attenuation of fasting hyperglycemia and glucose intolerance in obese
CD14−/− mice
Diet-induced obesity was accompanied by fasting hyperglycemia
and glucose intolerance in WT and CD14−/− mice. However, obese
CD14−/− group presented lower fasting plasma glucose (Table 1) and
blunted glucose intolerance (Fig. 3), compared to obese WT group. No
Fig. 2.Macrophage inﬁltration into fat tissue and adipocyte size in obeseWTand CD14−/−mice. In obeseWTand CD14−/−mice, fat tissue accumulationwas accompanied by increased
adipocyte size (A) and adipose tissue macrophage (ATM) content (B). However, obese CD14−/−mice presented lower adipocyte diameter and ATMs than the obese WT group. (C) The
fraction of F4/80-expressing macrophages was determined by immunohistochemical analysis of subcutaneous adipose tissue (×200). CD14−/−, CD14 knockout mice; WT, C57BL/6
mice; *Pb0.05 vs. Lean; †Pb0.05 vs. WT.
Fig. 3. Glucose homeostasis in WT and CD14−/− mice. Exposure to the HFHSC diet
resulted in impaired glucose homeostasis in both WT and CD14−/− mice. However,
CD14−/− obese mice presented lower fasting plasma glucose and blunted glucose
intolerance, compared with obese WT mice. No signiﬁcant differences were detected
between WT and CD14−/− lean groups. CD14−/−, CD14 knockout mice; WT, C57BL/6 mice;
*Pb0.05 vs. Lean; †Pb0.05 vs. WT.
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between WT and CD14−/− lean mice.
Given that no differences were detected in the insulin resistance
tests between lean and obeseWTgroups (data not shown), we did not
compare insulin resistance of WT and CD14−/− groups.
Hypertension is attenuated in obese CD14−/− mice
Systolic blood pressure elevation was observed in WT and CD14−/−
mice fed the HFHSC (Fig. 4A). Nevertheless, systolic blood pressures of
obese CD14−/− mice were lower than those of obese WT group.
Blunted sympathetic overactivity in obese CD14−/− mice
In WT mice, obesity was accompanied by increased sympathetic
activity, as evaluated by the noradrenaline excretion in 24-hour urine
(Fig. 4B). In contrast, no signiﬁcant differences were detected in
noradrenaline urinary excretion between lean and obese CD14−/−
mice.
Fig. 4. Non-invasive blood pressure and basal sympathetic activity evaluation. (A) Exposure to the high-fat high-simple carbohydrate diet for 12 weeks resulted in a signiﬁcant
elevation of systolic BP in WT and CD14−/− groups. However, systolic BP in obese CD14−/− mice was signiﬁcantly lower than in obese WT group. (B) In WT mice, obesity was
accompanied by increased sympathetic nervous system activity (evaluated by the excretion of NA in 24-hour urine), whereas in CD14−/−mice no differences were detected between
lean and obese groups. BP, blood pressure; CD14−/−, CD14 knockout mice; NA, noradrenaline; WT, C57BL/6 mice; *Pb0.05 vs. Lean; †Pb0.05 vs. WT.
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mice
Obesity was accompanied by hepatic lipid accumulation inWTand
CD14−/− mice, as evaluated by liver triglyceride quantiﬁcation and
qualitative histological analysis (Fig. 5A). Hepatic steatosis was
attenuated in obese CD14−/− mice, compared with obese WT group.
Obesity did not signiﬁcantly affect liver Kupffer cell content, both
in WT and CD14−/− mice (Fig. 5B). However, lean and obese CD14−/−
mice presented lower Kupffer cell content than the respective WT
groups.Fig. 5. Hepatic steatosis and Kupffer cell content in obese WT and CD14−/− mice. (A) Obesit
However, obese CD14−/− mice had lower hepatic steatosis than obese WT group. Hematoxy
CD14−/− (lower right) mice (×200). (B) The Kupffer cell content was reduced in CD14−/− lean
not recruit monocytes into the liver, both in WT and CD14−/− groups. The fraction of F4/80-
tissue (×400). CD14−/−, CD14 knockout mice; WT, C57BL/6 mice;*Pb0.05 vs. Lean; †Pb0.05Gene expression proﬁle, TLR4 immunodetection and macrophage
inﬁltration into adipose tissue of obese WT and CD14−/− mice
In WT mice, obesity was accompanied by an upregulation of CD14
and TLR2 gene expression in the liver (Fig. 6). This was paralleled by
increased TLR4 mRNA levels in visceral fat and by enhanced TLR2
expression in subcutaneous fat. In obese CD14−/− mice, TLR4 gene
activation was present in both subcutaneous and visceral fat, whereas
TLR2 upregulation was restricted to the subcutaneous fat.
In obese mice, macrophage inﬁltration into adipose tissue was
observed inWTand CD14−/− groups (Fig. 2B). However, themacrophagey was accompanied by increased triglyceride liver content in WT and CD14−/− groups.
lin and eosin-stained sections of liver showing steatosis in obese WT (lower left) and
and obese mice compared with the respective WT lean and obese groups. Obesity did
expressing Kupffer cells was determined by immunohistochemical analysis of hepatic
vs. WT.
Fig. 6. Gene expression proﬁle in hepatic, visceral and subcutaneous fat tissues. In WT mice, obesity activated CD14 and TLR2 gene expression in the liver. This was accompanied by
increased TLR4 mRNA levels in visceral fat and by enhanced TLR2 expression in subcutaneous fat. In obese CD14−/−mice, TLR4 gene activation was present in both subcutaneous and
visceral fat, and TLR2 mRNA levels were enhanced in subcutaneous fat. CD14−/−, CD14 knockout mice; WT, C57BL/6 mice;*Pb0.05 vs. Lean; †Pb0.05 vs. WT.
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compared with the respective WT groups.
Subcutaneous fat TLR4 immunostaining revealed TLR4 expression
both in adipose tissue macrophages and adipocytes, being less
pronounced in the latter. This occurred in both WT and CD14−/−
mice, in lean and obese groups (Fig. 7).
LPS-induced TLR4 activation in subcutaneous fat tissues
In order to evaluate the integrity of TLR4 signaling pathways in
both WT and CD14−/− mice, subcutaneous fat tissues were incubated
with the TLR4 agonist LPS, in a culture medium containing exogenous
sCD14 (Fig. 8). In obese WT group, 120 min incubation of fat tissue
with LPS resulted in a two-fold increase of TLR2mRNA levels, whereas
in leanWTgroup it did not signiﬁcantly change TLR2 gene expression.
TNF-α mRNA expression in adipose tissue and protein levels in the
adipose tissue culture supernatants increased after incubation with
LPS in obese WT mice.
A similar pattern of LPS-induced gene activation was observed in
CD14−/− mice. In fact, LPS-induced TLR2 and TNF-α mRNA upregula-
tion was restricted to the obese group.
Discussion
In the present study, obesity was accompanied by enhanced TLR4
gene expression and activity in adipose tissues. In fact, obeseWTmicepresented higher TLR4 mRNA levels and enhanced LPS-induced pro-
inﬂammatory gene activation in adipose tissues, compared with lean
WT group. These results are in agreement with previous reports
showing TLR4 upregulation in fat tissues of genetically obese mice as
well as in mouse models of diet-induced obesity (Lin et al., 2000; Shi
et al., 2006). Of note, TLR4 and TLR2 were differently regulated: TLR4
gene upregulation was restricted to the visceral fat of obese WT mice,
while TLR2 mRNA levels were elevated in the liver and subcutaneous
fat. This could be relevant given the accumulating data implicating
TLR2-mediated signaling in the metabolic complications of obesity. In
a recent study, Senn demonstrated that TLR2 is essential for the
development of free fatty acid-induced insulin resistance (Senn,
2006). Moreover, TLR2 synthesis in both adipocytes and hepatocytes
was shown to be strongly induced by TLR4 signaling (Lin et al., 2000),
and could mediate the enhanced inﬂammatory response under
inﬂammatory conditions (Senn, 2006). A three-fold increase of CD14
mRNA levels was also observed in the liver of obese WT mice. In a
recent report, LPS circulating levels were found to be increased by 2–3
times in mice exposed to a high-fat diet, a threshold that was
designated ‘metabolic endotoxemia’ (Cani et al., 2007). Given that the
liver is the main source of the LPS ligand sCD14, it is tempting to
speculate that CD14 upregulation in the hepatic tissue of obese WT
mice might play a role in TLR4 activation induced by ‘metabolic
endotoxemia’.
Interestingly, TLR4 and TLR2 gene activationwas observed in obese
mice lacking CD14, and immunodetection showed presence of TLR4 in
Fig. 7. Immunohistochemical analysis of TLR4 in subcutaneous fat tissues. TLR4 immunostaining in subcutaneous fat tissues revealed receptor expression in adipose tissue
macrophages and adipocytes, being less pronounced in the latter (×400). This occurred in both WT and CD14−/− mice, in lean and obese groups. CD14−/−, CD14 knockout mice;
WT, C57BL/6 mice. A representative example of TLR4 immunostaining in adipocytes (arrow) and adipose tissue macrophage (arrowhead) is indicated in the left and right lower
panels, respectively.
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CD14−/− mice. Furthermore, in the presence of exogenous sCD14, LPS-
induced TLR4 activation in subcutaneous fat tissues of CD14−/− obese
mice was also preserved. These results suggest intact TLR signaling
pathways in CD14−/− mice, so that differences in phenotype between
WT and CD14−/− mice could solely be attributed to impaired CD14-
dependent TLR activation. This could be particularly relevant, given
that it remains to be determined if there are CD14-independent but
TLR4- or TLR2-dependent responses in obesity. Namely, it is still not
known if TLR4 and TLR2 activation by nutritional fatty acids in obesity
is mediated by CD14 (Lee and Hwang, 2006). Of note, CD14-
independent and TLR4-dependent responses have already been
described in such different contexts as bacterial infection (Viriyakosol
et al., 2006) and leukocyte–endothelial interactions (Andonegui et al.,
2002).
CD14−/− mice exposed to the HFHSC diet showed similar weight
gain but lower adiposity and higher muscle mass than obese WT
group. The results agree well with a previous work reporting that this
transgenic strain has low body fat and gains less adiposity with aging,
while showing increased lean body mass (Johnson et al., 2004).
Moreover, the adipose tissue of CD14−/− mice presented lower
macrophage content than their WT counterparts. This could have
inﬂuenced the phenotype of the transgenic animals, given that
monocyte inﬁltration into adipose tissues has been implicated in the
low-grade chronic inﬂammatory state of obesity (Di Gregorio et al.,
2005; Weisberg et al., 2003). In fact, obese mice lacking either the C–C
motif chemokine receptor-2 (CCR2) or the CCR2 ligand monocyte
chemoattractant protein-1 (MCP-1) have reduced macrophage inﬁl-
tration into adipose tissue, with reduced inﬂammatory activation and
blunted metabolic complications (Kanda et al., 2006; Weisberg et al.,
2006).
In WT mice, obesity was accompanied by sympathetic nervous
system activation, as evaluated by the excretion of noradrenaline in24-hour urine. Sympathetic overactivity has been consistently
reported in both animal models and human obesity, and has been
proposed to underlie blood pressure elevation in this disease (Lembo
et al., 1992; Tentolouris et al., 2006). In fact, several experimental and
clinical studies showed a positive correlation between the urinary
excretion of noradrenaline and hypertension (Aneja et al., 2004). In
our study, obesity was not accompanied by sympathetic overactivity
in CD14 knockout mice, with hypertension being attenuated in this
experimental group. High-fat feeding has been recently shown to
increase plasma LPS by 2–3 times in mice, a threshold deﬁned as
‘metabolic endotoxemia’ (Cani et al., 2007). It has also been
demonstrated that peripherally administered LPS enhances noradre-
naline biosynthesis in the mouse locus ceruleus (Ota et al., 2007).
Given the central role of this brain stem nucleus in stress-induced
sympathetic activation, ‘metabolic endotoxemia’ could represent a
stimulus for sympathetic overactivity in obesity, through a CD14
dependent pathway in the central nervous system.
Exposure of the WT mice to the HFHSC diet for 12 weeks was
accompanied by alterations in glucose homeostasis, with elevated
fasting plasma glucose and glucose intolerance. However, obese WT
mice did not show insulin resistance. These results are in agreement
with previous reports showing that short-term high-fat feeding in
C57BL/6 mice could affect insulin sensitivity and glucose tolerance
independently. This mouse strain shows glucose intolerance despite
relatively good insulin sensitivity of peripheral tissues early in diet-
induced obesity (Rossmeisl et al., 2003), whereas insulin resistance
has been consistently reported after 6 months of HFHSC diet exposure
(Surwit et al., 1988). Although obesity also impaired glucose home-
ostasis in CD14−/−mice, fasting plasma glucose was lower and glucose
intolerancewas attenuated compared to obeseWTmice. These results
are in agreement with previous studies showing blunted type 2
diabetes mellitus in TLR4−/− and CD14−/− obese mice exposed to high-
fat diets (Cani et al., 2007; Shi et al., 2006).
Fig. 8. Adipose tissue incubations with LPS in WT and CD14−/− lean and obese mice. Incubation of subcutaneous fat of obese mice with LPS (5 μg/ml) in a culture medium containing
sCD14 during 120 min enhanced TLR2 (upper graph) and TNF-α (middle graph) mRNA levels, both in WT and CD14−/− groups. TNF-α protein was also increased in culture
supernatants of obese mice after 120 min of LPS incubation, although in CD14−/− group it did not reach statistical signiﬁcance. CD14−/−, CD14 knockout mice; WT, C57BL/6 mice;
*Pb0.05 vs. Vehicle; †Pb0.05 vs. Lean.
509R. Roncon-Albuquerque Jr. et al. / Life Sciences 83 (2008) 502–510In our study, liver CD14 mRNA levels were increased in obese WT
mice and CD14 inhibition was accompanied by a reduction in hepatic
steatosis and liver Kupffer cell content. Moreover, liver TLR2 upregula-
tion in obesity was restricted to the WT group. This could be relevant,
given the established role of innate immunity andKupffer cell activation
in the progression of non alcoholic steatosis to steatohepatitis and
ﬁbrosis (Kolios et al., 2006; Tomita et al., 2006). In obesity, enhanced
intestinal mucosa permeability with increased portal LPS has been
proposed to underlie non-alcoholic fatty liver disease (Brun et al., 2007).
In fact, ob/ob and db/db mice have decreased intestinal resistance with
enhanced LPS-induced pro-inﬂammatory and ﬁbrogenic responses in
hepatic stellate cells, which present higher mCD14 expression. More-
over, in the methionine–choline deﬁcient diet-induced model of non-
alcoholic steatohepatitis, TLR4-mediated liver injury and inﬂammatory
cytokine induction are enhanced (Szabo et al., 2005).
Finally, it should be mentioned that the attenuation of the
cardiovascular and metabolic complications of obesity in mice lacking
CD14 could havebeenmediatedbyadipokines. Although this hypothesis
was not speciﬁcally addressed in the present study, a large body of
evidence supports a critical role of adipokines such as leptin,
adiponectin, resistin and visfatin in the pathophysiology of obesity
(Ahima and Osei, 2008). Moreover, several studies have described
interplays between TLR signaling and adipokines. In a recent report,signiﬁcant upregulation of TLR1 to −9 expression in preadipocytes and
adipocytes of ob/ob and db/db mice was demonstrated, revealing a
strong regulation of TLR expression by leptin (Batra et al., 2007). In a
different study, adiponectin has been shown to negatively regulate
macrophage-like cell response to TLR ligands (Yamaguchi et al., 2005).
In conclusion, CD14 inhibition resulted in lower adiposity and
hepatic steatosis, improved glucose homeostasis, blunted sympathetic
overactivity and reduced blood pressure elevation of obese mice
exposed to a HFHSC diet. This was observed in the presence of
preserved TLR4 and TLR2 gene expression, and intact TLR4 signaling
pathways. The results of the present study suggest a role for CD14-
dependent TLR activation in the cardiovascular and metabolic
complications of obesity, and could contribute for the establishment
of novel therapeutic targets in the metabolic syndrome.
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